# Primary Palatine Tonsil Non-Hodgkin Lymphoma in Western Romania: A Comparison of Lower-Stage and Advanced-Stage Disease

**Authors:** Raluca Morar, Norberth-Istvan Varga, Delia Ioana Horhat, Ion Cristian Mot, Nicolae Constantin Balica, Alina-Andree Tischer, Monica Susan, Razvan Susan, Diana Luisa Lighezan, Rodica Anamaria Negrean

PMC · DOI: 10.3390/hematolrep17020017 · 2025-03-28

## TL;DR

This study examines non-Hodgkin lymphoma in the tonsils of patients in Western Romania, comparing outcomes between early and advanced stages of the disease.

## Contribution

The study provides insights into primary palatine tonsil NHL in a region with limited healthcare access, comparing lower- and advanced-stage disease characteristics.

## Key findings

- Advanced-stage disease was more common (55.9%) and associated with higher B symptoms and elevated LDH levels.
- Combined chemoradiotherapy was more frequently used in lower-stage disease.
- No significant difference in relapse rates was observed between the groups.

## Abstract

Background: Limited data exist on primary palatine tonsil Non-Hodgkin lymphoma (NHL) from regions with constrained healthcare access. This study investigated this malignancy in Western and South-Western Romania, comparing lower-stage (Ann-Arbor I-III) and advanced-stage (IV) disease. Methods: A retrospective cohort study (2010–2019) at a tertiary referral hospital included 59 patients with primary palatine tonsil NHL. Data on demographics, clinical presentation, comorbidities (including viral hepatitis B/C), histology, International Prognostic Index (IPI) score, treatment, and outcomes were collected. Statistical comparisons between lower-stage (n = 26) and advanced-stage (n = 33) groups were performed. Results: A high proportion presented with advanced-stage disease (55.9%). The advanced-stage group had significantly more B symptoms (90.9% vs. 69.2%, p = 0.038) and elevated LDH levels (93.9% vs. 57.7%, p = 0.013). Viral hepatitis B and/or C infection was more frequent in advanced-stage disease (30.3% vs. 15.4%, p = 0.44). Combined chemoradiotherapy was more commonly used in lower-stage disease (38.46% vs. 12.12%, p = 0.019). There was no statistically significant difference in relapse rates between the groups. Conclusions: This study highlights the substantial burden of advanced-stage primary palatine tonsil NHL in Western Romania, suggesting a need for improved early detection. The association between viral hepatitis and advanced-stage, although not statistically significant, warrants further investigation. These findings may inform tailored management approaches in resource-constrained settings.

## Linked entities

- **Diseases:** Non-Hodgkin lymphoma (MONDO:0018908), viral hepatitis B (MONDO:0005344)

## Full-text entities

- **Diseases:** viral hepatitis B/C (MESH:D006525), NHL (MESH:D008228), malignancy (MESH:D009369), Viral hepatitis B and/or C infection (MESH:D014777)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12026754